Non-small Cell Lung Cancer - Non-squamous First-line
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer - Non-squamous First-line.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC). [Phase 3]
Phase 3 trial comparing TQB2450 plus chemotherapy followed by TQB2450 plus anlotinib versus tislelizumab plus chemotherapy followed by tisle…